• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD CONNECTA¿ MULTIFLO¿ 3-WAY MULTIPLE INFUSION MANIFOLD; STOPCOCK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD CONNECTA¿ MULTIFLO¿ 3-WAY MULTIPLE INFUSION MANIFOLD; STOPCOCK Back to Search Results
Catalog Number 394601
Device Problem Leak/Splash (1354)
Patient Problem Chemical Exposure (2570)
Event Date 02/01/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd connecta¿ multiflo¿ 3-way multiple infusion manifold leaked adriablastine from the connection to the bag when connecting the lipiodol.This complaint was created to capture the 1st of 2 related incidents.The following information was provided by the initial reporter, translated from french: "incident occurred on (b)(6) 2023 during a chemoembolization procedure.The chemoembolization bag containing adriablastine was connected to a becton dickinson laboratory 3-way valve, reference 394601.Upon connecting the lipiodol (iodinated contrast material) to the 3-way valve, the adriablastine was projected into the air.The intern was sprayed in the neck (vesicant drug ++), and a technician was also sprayed.The patient was not affected by these.It is recurrent that this tap reference leaks, a tray is always placed under the tap to collect the spills, but this is the first time that the product used is projected in the air.The intern wiped and rinsed the area thoroughly for 15 minutes and contacted upco for further action.The product, contaminated with chemo was disposed of.Current status of the patient: no clinical consequence for the patient/ but the product is vesicant, risk for the patient and the technicians of serious skin reactions.Actions taken in the health care institution for the management of the patient: change of tap by one of the same reference to start a new treatment".
 
Manufacturer Narrative
Investigation summary: bd was unable to perform a thorough investigation as no sample, lot, or batch number were provided.A device history review could not be completed as no batch number was provided.
 
Event Description
It was reported that the bd connecta¿ multiflo¿ 3-way multiple infusion manifold leaked adriablastine from the connection to the bag when connecting the lipiodol.This complaint was created to capture the 1st of 2 related incidents.The following information was provided by the initial reporter, translated from french: "incident occurred on (b)(6) 2023 during a chemoembolization procedure.The chemoembolization bag containing adriablastine was connected to a becton dickinson laboratory 3-way valve, reference (b)(4).Upon connecting the lipiodol (iodinated contrast material) to the 3-way valve, the adriablastine was projected into the air.The intern was sprayed in the neck (vesicant drug ++), and a technician was also sprayed.The patient was not affected by these.It is recurrent that this tap reference leaks, a tray is always placed under the tap to collect the spills, but this is the first time that the product used is projected in the air.The intern wiped and rinsed the area thoroughly for 15 minutes and contacted upco for further action.The product, contaminated with chemo was disposed of.Current status of the patient: no clinical consequence for the patient/ but the product is vesicant, risk for the patient and the technicians of serious skin reactions.Actions taken in the health care institution for the management of the patient: change of tap by one of the same reference to start a new treatment.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD CONNECTA¿ MULTIFLO¿ 3-WAY MULTIPLE INFUSION MANIFOLD
Type of Device
STOPCOCK
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16900218
MDR Text Key314900200
Report Number9610847-2023-00105
Device Sequence Number1
Product Code FMG
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number394601
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-